MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$258,445K
(-63.72%↓ Y/Y)
Unrealized gain on
marketable securities
$312K
(5100.00%↑ Y/Y)
Net loss
-$258,757K
(-63.91%↓ Y/Y)
Investment and other
income, net
$28,610K
(-23.12%↓ Y/Y)
Grant
$1,448K
Service
$97K
Operating loss
-$287,367K
(-47.31%↓ Y/Y)
Total revenues
$1,545K
(11784.62%↑ Y/Y)
Total operating
expenses
$288,912K
(42.96%↑ Y/Y)
Research and development
$245,074K
(49.85%↑ Y/Y)
General and
administrative
$43,838K
(13.72%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Celldex Therapeutics, Inc. (CLDX)
Celldex Therapeutics, Inc. (CLDX)